Therapeutic potential of elafin in airway inflammatory disease
Authors:
Open Access
- 1 January 2024
- journal article
- review article
- Published by SAGE Publications in European Journal of Inflammation
- Vol. 22
Abstract
Elafin, which is derived from trappin-2 or pre-elafin by proteolysis, is an endogenous serine protease inhibitor with a low molecular weight. Its inhibitory activity is dependent on anchoring to the extracellular matrix by forming covalent bonds with its distinctive N-terminal domain via tissue transglutaminases. In addition to inhibiting proteases, it also exhibits anti-inflammatory, antibiotic, antifungal, antiviral and immunomodulatory functions. Elafin plays an important role in inflammatory disease and is a promising candidate for the anti-inflammatory treatment of respiratory diseases. This review will discuss the therapeutic potential of elafin in airway inflammation and provide evidence and suggestions for the future treatment of airway inflammatory diseases. In addition, the therapeutic potential of elafin in lung cancer is also discussed.Keywords
Funding Information
- NHC Key Laboratory of Tropical Disease Control, Hainan Medical University (2021NHCTDCKFKT21008)
- National Natural Science Foundation of China (82260001, 81860001, 82160012)
- Hainan Provincial Science and Technology Major Project (ZDKJ2021036, ZDKJ202004, ZDKJ2021038)
- Province Innovation Team Project of Hainan (820CXTD448)
- Hainan Province Key R&D Program International Science and Technology Cooperation Project (GHYF2022011)
- Key R&D Projects in Hainan Provinc (ZDYF2020223)
- Hainan Provincial Clinical Medical Center Construction Project Fund
- Chinese Academy of Medical Sciences Medical and Health Science and Technology Innovation Engineering Project (2019-12M-5-023)
- Hainan Provincial Natural Science Foundation of China (822MS071)
This publication has 69 references indexed in Scilit:
- Inhibition of neutrophil elastase prevents neutrophil extracellular trap formation and rescues mice from endotoxic shockBiomaterials, 2020
- Inflammation and Cancer: Triggers, Mechanisms, and ConsequencesImmunity, 2019
- Recombinant human elafin promotes alveologenesis in newborn mice exposed to chronic hyperoxiaThe International Journal of Biochemistry & Cell Biology, 2017
- Normal saline instillation before suctioning: A meta-analysis of randomized controlled trialsAustralian Critical Care, 2017
- Complete 1H, 15N and 13C assignment of trappin-2 and 1H assignment of its two domains, elafin and cementoinBiomolecular NMR Assignments, 2016
- Cysteine proteases: mode of action and role in epidermal differentiationCell and tissue research, 2013
- The WAP protein Trappin-2/Elafin: A handyman in the regulation of inflammatory and immune responsesThe International Journal of Biochemistry & Cell Biology, 2012
- Epigenetic regulation of the transcription factor Foxa2 directs differential elafin expression in melanocytes and melanoma cellsBiochemical and Biophysical Research Communications, 2011
- Protease inhibitors derived from elafin and SLPI and engineered to have enhanced specificity towards neutrophil serine proteasesProtein Science, 2009
- Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin familyBiochimie, 2008